Jan-22-21 Upgrade
Raymond James
Mkt Perform → Outperform
$250
May-12-20 Downgrade
JP Morgan
Neutral → Underweight
$120 → $158
Mar-26-20 Downgrade
Barclays
Overweight → Equal Weight
$90
Oct-23-18 Resumed
Raymond James
Strong Buy
$80
Mar-08-18 Upgrade
Raymond James
Outperform → Strong Buy
Jan-22-18 Reiterated
Barclays
Overweight
$50 → $60
Jan-04-18 Upgrade
CL King
Neutral → Buy
Sep-19-17 Upgrade
Piper Jaffray
Neutral → Overweight
Jul-18-17 Upgrade
William Blair
Mkt Perform → Outperform
Jul-18-17 Upgrade
Canaccord Genuity
Hold → Buy
$25 → $42
Apr-25-17 Reiterated
Canaccord Genuity
Hold
$24 → $24.50
Feb-17-17 Initiated
CL King
Neutral
Dec-16-16 Downgrade
Piper Jaffray
Overweight → Neutral
Jun-13-16 Upgrade
Raymond James
Mkt Perform → Outperform
Feb-18-16 Reiterated
Barclays
Overweight
$28 → $22
Feb-09-16 Downgrade
Canaccord Genuity
Buy → Hold
$22 → $18
Jan-08-16 Reiterated
Canaccord Genuity
Buy
$25 → $22
Dec-14-15 Downgrade
Raymond James
Outperform → Mkt Perform
Sep-02-15 Initiated
Barclays
Overweight
$28
Jul-31-13 Reiterated
Canaccord Genuity
Buy
$30 → $35
Jan-22-21 09:38AM
Jan-20-21 06:18AM
Jan-19-21 05:11PM Investor's Business Daily
01:29PM
01:13PM Investor's Business Daily
10:30AM
09:56AM
Jan-18-21 10:08AM
07:59AM
Jan-17-21 04:18PM
Jan-14-21 05:45PM
12:45PM
11:51AM
11:40AM
Jan-13-21 10:18AM
Jan-12-21 09:09AM
Jan-08-21 10:16AM
Jan-07-21 02:15PM
10:25AM
07:15AM Investor's Business Daily
Jan-05-21 05:14PM Investor's Business Daily +5.03%
11:30AM
10:02AM
09:22AM
08:04AM
Dec-24-20 05:50PM
10:36AM
Dec-23-20 01:30PM
Dec-21-20 03:08PM
02:25PM
10:01AM
08:30AM
08:24AM
07:10AM
Dec-17-20 05:50PM
Dec-14-20 02:39PM
Dec-11-20 05:20AM
Dec-10-20 06:00PM
11:34AM
Dec-09-20 08:07AM
06:50AM
Dec-06-20 06:24AM
Dec-05-20 06:17AM
Dec-03-20 08:48AM
Dec-02-20 11:43AM
Dec-01-20 08:33AM
Nov-27-20 12:45PM
07:38AM
Nov-25-20 11:30AM
03:18AM
Nov-19-20 10:00AM
10:00AM
Nov-16-20 09:40AM
Nov-13-20 10:02AM
08:33AM
08:15AM Investor's Business Daily
Nov-10-20 06:00PM
11:00AM
10:00AM
Nov-09-20 03:52PM Investor's Business Daily -28.15%
11:30AM
Nov-08-20 03:29AM
Nov-07-20 06:30AM
Nov-05-20 01:31PM
Nov-04-20 03:25PM Investor's Business Daily
Nov-03-20 04:10PM
Nov-02-20 08:40AM
Oct-29-20 07:15PM
05:12PM
04:10PM
03:14PM
12:51PM
12:07PM
Oct-28-20 11:51AM
10:28AM
09:26AM
Oct-27-20 10:36AM
Oct-26-20 05:02PM
11:54AM Investor's Business Daily Video
Oct-23-20 11:36AM
11:30AM
Oct-22-20 05:50PM
12:33PM
08:00AM
Oct-21-20 08:43AM
05:37AM
Oct-19-20 04:10PM
Oct-17-20 07:09AM
Oct-16-20 08:54AM
Oct-12-20 09:00AM
Oct-09-20 01:56PM
01:12PM
Oct-08-20 08:39AM
Oct-07-20 09:10PM
06:05PM
11:30AM
Oct-06-20 12:10PM
12:05PM
07:58AM
Oct-05-20 09:39AM Investor's Business Daily +6.94%
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
POLAN MARY LAKE PH D Director Dec 01 Sale 192.25 11,000 2,114,797 24,329 Dec 03 07:32 PM POLAN MARY LAKE PH D Director Nov 06 Sale 284.17 3,000 852,505 35,329 Nov 06 07:19 PM SLACIK CHARLES P Director Nov 05 Option Exercise 20.82 4,009 83,467 15,224 Nov 06 07:16 PM SLACIK CHARLES P Director Nov 05 Sale 282.46 4,009 1,132,388 11,215 Nov 06 07:16 PM POLAN MARY LAKE PH D Director Oct 23 Option Exercise 21.63 27,188 588,142 38,329 Oct 27 07:37 PM POLAN MARY LAKE PH D Director Oct 12 Sale 275.83 11,743 3,239,015 11,141 Oct 14 07:26 PM Strobeck Matthew Director Sep 03 Buy 155.63 400 62,254 38,145 Sep 04 07:09 PM Strobeck Matthew Director Sep 02 Buy 166.65 7,300 1,216,511 37,745 Sep 04 07:09 PM BRYANT DOUGLAS C President & CEO Aug 31 Buy 174.99 5,000 874,965 455,823 Sep 01 06:05 PM Abney Michael Donald Jr. SVP - Distribution Aug 20 Option Exercise 34.14 2,582 88,143 9,216 Aug 24 12:03 PM Abney Michael Donald Jr. SVP - Distribution Aug 20 Sale 250.00 2,582 645,500 6,634 Aug 24 12:03 PM Abney Michael Donald Jr. SVP - Distribution Aug 19 Option Exercise 35.87 5,610 201,215 12,244 Aug 24 12:03 PM Abney Michael Donald Jr. SVP - Distribution Aug 19 Sale 250.00 5,610 1,402,500 6,634 Aug 24 12:03 PM BRYANT DOUGLAS C President & CEO Aug 11 Buy 234.12 5,000 1,170,600 450,823 Aug 11 08:38 PM BUECHLER KENNETH F Director Aug 03 Option Exercise 14.43 7,800 112,554 67,624 Aug 05 08:26 PM STEWARD RANDALL J Chief Financial Officer Aug 03 Option Exercise 18.46 21,166 390,657 24,014 Aug 05 08:33 PM Michael Edward L. Director Aug 03 Buy 288.12 3,500 1,008,404 6,434 Aug 05 08:32 PM Kroll Werner SVP, R&D Aug 03 Sale 287.48 2,072 595,650 4,599 Aug 05 08:28 PM BUECHLER KENNETH F Director Aug 03 Sale 289.22 7,800 2,255,946 59,824 Aug 05 08:26 PM STEWARD RANDALL J Chief Financial Officer Aug 03 Sale 286.31 21,166 6,060,126 2,848 Aug 05 08:33 PM BRYANT DOUGLAS C President & CEO Jun 11 Buy 160.33 5,000 801,670 445,823 Jun 12 05:53 PM Kroll Werner SVP, R&D May 27 Option Exercise 0.00 4,376 0 8,975 May 27 07:54 PM Kroll Werner SVP, R&D May 22 Option Exercise 20.46 68,152 1,394,422 72,751 May 27 07:54 PM Kroll Werner SVP, R&D May 22 Sale 174.44 68,152 11,888,149 4,599 May 27 07:54 PM Bujarski Robert Joseph SVP, NA Comm Ops & Gen Counsel May 20 Sale 189.41 20,000 3,788,282 13,383 May 22 07:59 PM Abney Michael Donald Jr. SVP - Distribution May 18 Option Exercise 17.95 15,970 286,675 15,432 May 20 08:02 PM BORKAR RATAN S SVP, Intl Comm Operations May 18 Option Exercise 31.88 16,332 520,699 27,171 May 20 08:07 PM Abney Michael Donald Jr. SVP - Distribution May 18 Sale 198.46 15,970 3,169,387 6,634 May 20 08:02 PM STEWARD RANDALL J Chief Financial Officer May 18 Sale 185.35 20,000 3,707,040 2,848 May 20 08:11 PM BORKAR RATAN S SVP, Intl Comm Operations May 18 Sale 192.82 28,312 5,459,113 524 May 20 08:07 PM SLACIK CHARLES P Director May 15 Option Exercise 0.00 549 0 11,352 May 18 08:16 PM BUECHLER KENNETH F Director May 15 Option Exercise 0.00 1,842 0 59,824 May 18 08:06 PM WIDDER KENNETH J Director May 14 Option Exercise 0.00 2,100 0 14,416 May 18 08:21 PM Strobeck Matthew Director May 14 Option Exercise 0.00 2,100 0 7,399 May 18 08:19 PM SLACIK CHARLES P Director May 14 Option Exercise 0.00 2,100 0 10,803 May 18 08:16 PM SCHULER JACK W Director May 14 Option Exercise 0.00 2,100 0 3,103,249 May 18 08:14 PM POLAN MARY LAKE PH D Director May 14 Option Exercise 0.00 2,100 0 22,884 May 18 08:12 PM ORDONEZ KATHY Director May 14 Option Exercise 0.00 1,856 0 1,856 May 18 08:10 PM Michael Edward L. Director May 14 Option Exercise 0.00 2,100 0 2,934 May 18 08:08 PM BUECHLER KENNETH F Director May 14 Option Exercise 0.00 2,100 0 57,982 May 18 08:06 PM POLAN MARY LAKE PH D Director May 11 Sale 204.27 6,700 1,368,630 20,784 May 12 08:01 PM BUECHLER KENNETH F Director May 11 Sale 200.00 5,000 1,000,000 55,882 May 13 08:01 PM BUECHLER KENNETH F Director May 05 Option Exercise 13.25 10,449 138,449 60,882 May 07 08:05 PM Russell Edward Keith SVP, Business Development Feb 26 Option Exercise 15.40 12,601 194,055 29,791 Feb 28 08:03 PM Russell Edward Keith SVP, Business Development Feb 26 Sale 79.58 12,601 1,002,796 17,190 Feb 28 08:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite